[1]
|
Cushman M. Epidemiology and risk factors for venous thrombosis[J]. Semin Hematol, 2007, 44:62-69. doi: 10.1053/j.seminhematol.2007.02.004 |
[2]
|
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition)[J]. Chest, 2008, 133:381S-453S. doi: 10.1378/chest.08-0656 |
[3]
|
Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism:a population-based, cohort study[J]. Arch Intern Med, 1999, 159:445-453. doi: 10.1001/archinte.159.5.445 |
[4]
|
Alikhan R, Peters F, Wilmott R, et al. Fatal pulmonary embolism in hospitalised patients:a necropsy review[J]. J Clin Pathol, 2004, 57:1254-1257. doi: 10.1136/jcp.2003.013581 |
[5]
|
Vessey M, Mant D, Smith A, et al. Oral contraceptives and venous thromboembolism:findings in a large prospective study[J]. Br Med J(Clin Res Ed), 1986, 292:526. doi: 10.1136/bmj.292.6519.526 |
[6]
|
Tyler ET. Oral contraception and venous thrombosis[J]. JAMA, 1963, 185:131-132. doi: 10.1001/jama.1963.03060020091034 |
[7]
|
Daly E, Vessey MP, Hawkins MM, et al. Risk of venous thromboembolism in users of hormone replacement therapy[J]. Lancet, 1996, 348:977-980. doi: 10.1016/S0140-6736(96)07113-9 |
[8]
|
Vene N. Hormone replacement therapy and venous thromboembolism[J]. Climacteric, 2014, 142:76-82. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1080/13697130802227724 |
[9]
|
Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters:a systematic review and meta-analysis[J]. Lancet, 2013, 382:311-325. doi: 10.1016/S0140-6736(13)60592-9 |
[10]
|
Piccioli A, Prandoni P, Ewenstein BM, et al. Cancer and venous thromboembolism[J]. Am Heart J, 1987, 147:694-699. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM8831376 |
[11]
|
Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer[J]. Am J Med, 2006, 119:60-68. doi: 10.1016/j.amjmed.2005.06.058 |
[12]
|
Sandhu R, Pan CX, Wun T, et al. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer[J]. Cancer, 2010, 116:2596-2603. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1002/cncr.25004 |
[13]
|
Anderson FA, Wheeler HB, Goldberg RJ, et al. A popula-tion-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study[J]. Arch Intern Med, 1991, 151:933-938. doi: 10.1001/archinte.1991.00400050081016 |
[14]
|
Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women[J]. JAMA, 1997, 277:642-645. doi: 10.1001/jama.1997.03540320044033 |
[15]
|
Matta F, Singala R, Yaekoub AY, et al. Risk of venous thromboembolism with rheumatoid arthritis[J]. Thromb Haemost, 2009, 101:134-138. doi: 10.1160/TH08-08-0551 |
[16]
|
Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease:a cohort study[J]. Lancet, 2010, 375:657-663. doi: 10.1016/S0140-6736(09)61963-2 |
[17]
|
Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease[J].Am J Gastroenterol, 2004, 99:97-101. doi: 10.1046/j.1572-0241.2003.04026.x |
[18]
|
Leizorovicz A, Mismetti P. Preventing venous thromboembo-lism in medical patients[J]. Circulation, 2004, 110:13-19. |
[19]
|
Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group[J]. N Engl J Med, 1999, 341:793-800. doi: 10.1056/NEJM199909093411103 |
[20]
|
Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients:randomised placebo controlled trial[J]. Br Med J, 2006, 332:325-329. doi: 10.1136/bmj.38733.466748.7C |
[21]
|
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism:the Padua Prediction Score[J]. Thromb Haemost, 2010, 8:2450-2457. doi: 10.1111/j.1538-7836.2010.04044.x |
[22]
|
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease:CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149:315-352. doi: 10.1016/j.chest.2015.11.026 |
[23]
|
Woo KS, Tse LKK, Tse CY, et al. The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong[J]. Int J Cardiol, 1988, 20:373-380. doi: 10.1016/0167-5273(88)90291-4 |
[24]
|
Liam CK, Ng SC. A review of patients with deep vein thrombosis diagnosed at University Hospital, Kuala Lumpur[J]. Ann Acad Med Singapore, 1990, 19:837-840. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM2130750 |
[25]
|
Lee LH. Clinical update on deep vein thrombosis in Singapore[J]. Ann Acad Med Singapore, 2002, 31:248-252. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM11957569 |
[26]
|
Cheuk BLY, Cheung GCY, Cheng SWK. Epidemiology of venous thromboembolism in a Chinese population[J]. Br J Surg, 2004, 91:424-428. doi: 10.1002/bjs.4454 |
[27]
|
Liu X, Liu C, Chen X, et al. Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism:a retrospective study[J]. Interact Cardiovasc Thorac Surg, 2016, 23:538-543. doi: 10.1093/icvts/ivw158 |
[28]
|
李积凤, 杨媛华.对《内科住院患者静脉血栓栓塞症预防的中国专家建议》的解读[J].中国医刊, 2016, 51:24-27. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyk201604009 |
[29]
|
王倩竹, 黄建平, 曾小兵, 等.结直肠癌患者术后并发静脉血栓栓塞的影响因素分析[J].中国全科医学, 2014, 17:659-662. doi: 10.3969/j.issn.1007-9572.2014.06.015 |
[30]
|
Anderson FA, Spencer FA. Risk factors for venous thromboembolism[J]. Circulation, 2003, 107:I9-I16. |
[31]
|
Giordano NJ, Jansson PS, Young MN, et al. Epidemiology, pathophysiology, stratification, and natural history of pulmon-ary embolism[J]. Tech Vasc Interv Radiol, 2017, 20:135-140. doi: 10.1053/j.tvir.2017.07.002 |
[32]
|
Duggirala MK, Cook DA, Mauck KF. An association between atherosclerosis and venous thrombosis[J]. N Engl J Med, 2003, 348:401-402. |
[33]
|
Caprini JA, Arcelus JI, Reyna J. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease[J]. Semin Hematol, 2001, 38:12-19. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM11449339 |
[34]
|
张学辉, 喻姣花, 褚婕, 等.深静脉血栓风险评估研究进展及展望[J].护理研究, 2014, (32):3982-3985. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=sxhlzz201432005 |
[35]
|
闫振宇, 华宝来, 马西虎, 等. 672例静脉血栓栓塞症相关危险因素分析[J].中华血液学杂志, 2007, 28:579-582. doi: 10.3760/j.issn:0253-2727.2007.09.002 |
[36]
|
中华医学会呼吸病学分会.肺血栓栓塞症的诊断与治疗指南(草案)[J].中国临床医生杂志, 2002, 24:26-30. http://www.cnki.com.cn/Article/CJFDTotal-ZLYS200204013.htm |
[37]
|
White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism[J]. Thromb Res, 2009, 123 Suppl 4:S11-S17. doi: 10.1016/S0049-3848(09)70136-7 |
[38]
|
White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996[J]. Thromb Haemost, 2005, 93:298-305. doi: 10.1160/TH04-08-0506 |
[39]
|
Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism:a 25-year population-based study[J]. AMA Arch Intern Med, 1998, 158:585-593. doi: 10.1001/archinte.158.6.585 |
[40]
|
White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California[J]. Ann Intern Med, 1998, 128:737-740. doi: 10.7326/0003-4819-128-9-199805010-00006 |
[41]
|
Stein PD, Kayali F, Olson RE, et al. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States:analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census[J]. Am J Med, 2004, 116:435-442. doi: 10.1016/j.amjmed.2003.11.020 |
[42]
|
Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting(ENDORSE study):a multinational cross-sectional study[J]. Lancet, 2008, 371:387-394. doi: 10.1016/S0140-6736(08)60202-0 |
[43]
|
Ge J, Li Y, Jin X, et al. Venous thromboembolism risk assessment and thromboprophylaxis among hospitalized acute medical patients in China-the RAMP study[J]. Thromb Res, 2010, 126:270-275. doi: 10.1016/j.thromres.2010.06.029 |
[44]
|
Listed N. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development[J]. JAMA, 1986, 256:744-749. doi: 10.1001/jama.1986.03380060070028 |
[45]
|
Oger E. Incidence of venous thromboembolism:a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale[J]. Thromb Haemost, 2000, 83:657-660. doi: 10.1055/s-0037-1613887 |
[46]
|
Zakai NA, Mcclure LA. Racial differences in venous thromboembolism[J]. Thromb Haemost, 2011, 9:1877-1882. doi: 10.1111/j.1538-7836.2011.04443.x |
[47]
|
Bang SM, Jang MJ, Oh D, et al. Korean Guidelines for the Prevention of Venous Thromboembolism[J]. J Korean Med Sci, 2010, 25:1553-1559. doi: 10.3346/jkms.2010.25.11.1553 |
[48]
|
Nakamura M. Japanese Guidelines for Prevention of Venous Thromboembolism Guideline[J]. J Jpn Soc Clin Anesth, 2004, 24:480-487. doi: 10.2199/jjsca.24.480 |
[49]
|
Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism[J]. Am J Surg, 2010, 199:S3-S10. doi: 10.1016/j.amjsurg.2009.10.006 |
[50]
|
Rosenberg D, Eichorn A, Alarcon M, et al. External validation of the risk assessment model of the international medical prevention registry on venous thromboembolism(IMPROVE)for medical patients in a tertiary health system[J]. J Am Heart Assoc, 2014, 3:e001152. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1161/JAHA.114.001152 |
[51]
|
Spyropoulos AC, Jr AF, Fitzgerald G, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE[J]. Chest, 2011, 140:706-714. doi: 10.1378/chest.10-1944 |
[52]
|
Wicki J, Perneger TV, Junod AF, et al. Patient-centered research:assessing clinical probability of pulmonary embolism in the emergency ward:a simple score[J]. J Arch Intern Med, 2001, 161:92-97. doi: 10.1001/archinte.161.1.92 |
[53]
|
Shi C, Kang X, Wang Y, et al. The coagulation factor V Leiden, MTHFRC677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke[J]. Clin Chim Acta, 2008, 396:7-9. doi: 10.1016/j.cca.2008.06.009 |
[54]
|
Jun ZJ, Ping T, Lei Y, et al. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism[J]. Clin Lab Haematol, 2006, 28:111-116. doi: 10.1111/j.1365-2257.2006.00757.x |
[55]
|
Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis:a qualitative overview and proposed classification system[J]. Ann Intern Med, 2003, 138:128-134. doi: 10.7326/0003-4819-138-2-200301210-00014 |
[56]
|
刘凤林, 秦净, 从指南到实践:解析《中国普通外科围手术期血栓预防与管理指南》[J].协和医学杂志, 2018, 9:44-49. http://www.cqvip.com/QK/70803X/201802/7000450781.html |
[57]
|
彭斌, 崔丽英.抗凝与出血:临床决策的平衡与选择[J].协和医学杂志, 2018, 9:7-12. http://www.cqvip.com/QK/70803X/201802/7000450774.html |